Epidemic of mumps among vaccinated persons, the Netherlands, 2009-2012

Emerging Infectious Diseases

Volumn 20, Issue 4, 2014, Pages 643-648

  Sane, Jussi ^a,b   Gouma, Sigrid ^a,c   Koopmans, Marion ^a,c   de Melker, Hester ^a   Swaan, Corien ^a   van Binnendijk, Rob ^a   Hahné, Susan ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; MEASLES MUMPS RUBELLA VACCINE; VIRUS RNA;

ADULT; AGE; ANTIBODY DETECTION; ARTICLE; ENCEPHALITIS; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEARING IMPAIRMENT; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MUMPS; ORCHITIS; PANCREATITIS; THYROIDITIS; ADOLESCENT; CHILD; EPIDEMIOLOGY; IMMUNOLOGY; INFANT; MUMPS VIRUS; NETHERLANDS; NEWBORN; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; MUMPS VIRUS; NETHERLANDS; YOUNG ADULT;

EID: 84896456615     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2004.131681     Document Type: Article

References (27)

1. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet. 2008;371:932-
2. http://dx.doi.org/10.1016/S0140-6736(08)60419-5
3. McLean HQ, Hickman CJ, Seward JF; World Health Organization Department of Immunization, Vaccines and Biologicals. The immunological basis for immunization series. Module 16: mumps. Geneva: The Organization; 2010 [cited 2014 Jan 10]. http://whqlibdoc. who.int/publications/2010/9789241500661_eng.pdf
4. van Lier EA, Oomen PJ, Oostenbrug MW, Zwakhals SL, Drijfhout IH, de Hoogh PA, et al. High vaccination coverage of the National Immunization Programme in the Netherlands [in Dutch]. Ned Tijdschr Geneeskd. 2009;153:950-7.
5. Brockhoff HJ, Mollema L, Sonder GJ, Postema CA, van Binnendijk RS, Kohl RH, et al. Mumps outbreak in a highly vaccinated student population, the Netherlands, 2004. Vaccine. 2010;28:2932-6. http://dx.doi.org/10.1016/j.vaccine.2010.02.020
6. Snijders BE, van Lier A, van de Kassteele J, Fanoy EB, Ruijs WL, Hulshof F, et al. Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008. Vaccine. 2012;30:2999-3002. http://dx.doi.org/10.1016/j.vaccine.2012.02.035
7. Greenland K, Whelan J, Fanoy E, Borgert M, Hulshof K, Yap KB, et al. Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine. 2012;30:4676-80. http://dx.doi.org/10.1016/j.vaccine.2012.04.083
8. Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, Yap K, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill. 2010;15:19554.
9. Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis. 2008;46:1172-80. http://dx.doi. org/10.1086/529141
10. Deeks SL, Lim GH, Simpson MA, Gagne L, Gubbay J, Kristjanson E, et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ. 2011;183:1014-20. http://dx.doi. org/10.1503/cmaj.101371
11. Calvert N, Ashton JR, Garnett E. Mumps outbreak in private schools: public health lessons for the post-Wakefield era. Lancet. 2013;381:1625-6. http://dx.doi.org/10.1016/S0140-6736(13)60953-8
12. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med. 2012;367:1704-13. http:// dx.doi.org/10.1056/NEJMoa1202865
13. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17:1055-65. http://dx.doi.org/10.1128/ CVI.00131-10
14. Smits G, Mollema L, Hahné S, de Melker H, Tcherniaeva I, Waaijenborg S, et al. Seroprevalence of mumps in the Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. PLoS ONE. 2013;8:e58234. http://dx.doi.org/10.1371/ journal.pone.0058234
15. Jokinen S, Osterlund P, Julkunen I, Davidkin I. Cellular immunity to mumps virus in young adults 21 years after measles-mumpsrubella vaccination. J Infect Dis. 2007;196:861-7. http://dx.doi. org/10.1086/521029
16. Hassan J, Dean J, Moss E, Carr MJ, Hall WW, Connell J. Seroepidemiology of the recent mumps virus outbreaks in Ireland. J Clin Virol. 2012;53:320-4. http://dx.doi.org/10.1016/j.jcv.2011.12.022
17. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007;13:12-7.
18. Ovsyannikova IG, Jacobson RM, Dhiman N, Vierkant RA, Pankratz VS, Poland GA. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics. 2008;121:e1091-9. http://dx.doi.org/10.1542/peds.2007-1575
19. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis. 2008;47:1458-67. http://dx.doi.org/10.1086/591196
20. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 1993;22:742-6. http://dx.doi. org/10.1093/ije/22.4.742
21. Quinlisk MP. Mumps control today. J Infect Dis. 2010;202:655-6. http://dx.doi.org/10.1086/655395
22. Cortese MM, Barskey AE, Tegtmeier GE, Zhang C, Ngo L, Kyaw MH, et al. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis. 2011;204:1413-22. http://dx.doi.org/10.1093/infdis/jir526
23. Hahné S, Whelan J, van Binnendijk R, Swaan C, Fanoy E, Boot H, et al. Mumps vaccine effectiveness against orchitis. Emerg Infect Dis. 2012;18:191-3. http://dx.doi.org/10.3201/eid1801.111178
24. Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis. 2011;17:661-7. http://dx.doi. org/10.3201/eid1704.101461
25. Opstelten W, Hahné SJ, van Roijen JH, van Paridon L, Wolters B, Swaan CM. Mumps makes a comeback [in Dutch]. Ned Tijdschr Geneeskd. 2012;156:A5187.
26. Everberg G. Deafness following mumps. Acta Otolaryngol. 1957;48:397-403. http://dx.doi.org/10.3109/00016485709126900 26. Hashimoto H, Fujioka M, Kinumaki H. An office-based prospective study of deafness in mumps. Pediatr Infect Dis J. 2009;28:173-5. http://dx.doi.org/10.1097/INF.0b013e31818a8ca8
27. Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, et al. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics. 2012;130:e1567-74. http://dx.doi. org/10.1542/peds.2012-0177